Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | +5.88% |
|
+7.46% | +144.07% |
21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+144.07% | 42.21M | |
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- DURECT : Chardan Suspends Coverage on Durect at Buy Rating With $8 Price Target